Summary

The global Proteomics market size is predicted to grow from US$ 35689 million in 2025 to US$ 67092 million in 2032; it is expected to grow at a CAGR of 9.8% from 2026 to 2032.
Proteomics is an advanced life science analytical discipline that systematically studies the complete set of proteins within biological systems, including protein identification, quantification, structural characterization, functional regulation, post-translational modifications, and protein interaction networks. As a critical bridge between genomic information and biological phenotypes, proteomics analyzes protein expression patterns and molecular changes in cells, tissues, blood, and other biological samples to reveal disease mechanisms, biological pathways, and therapeutic responses.
Modern proteomics relies on high-resolution mass spectrometry, liquid chromatography-tandem mass spectrometry (LC-MS/MS), affinity-based protein profiling, multiplex protein analysis platforms, single-cell proteomics, and spatial proteomics technologies to enable accurate detection and interpretation of hundreds to tens of thousands of proteins. Driven by precision medicine, biopharmaceutical innovation, oncology research, immunotherapy development, and AI-enabled biological data analysis, proteomics has evolved from a research methodology into an integrated industrial ecosystem covering analytical instruments, reagents and consumables, bioinformatics software, and specialized testing services. Its strategic importance lies in providing molecular insights for drug target discovery, biomarker identification, clinical diagnostics, and personalized therapeutic development.
The proteomics industry operates under an integrated business model combining advanced analytical instrument manufacturing, specialized reagent and consumable production, bioinformatics software development, and professional proteomics services. The upstream value chain includes suppliers of mass spectrometry components, optical systems, chromatography modules, biochemical reagents, antibodies, protein standards, and microarray materials. The midstream sector consists of proteomics instrument manufacturers, technology platform providers, software developers, and contract research organizations (CROs). The downstream market includes pharmaceutical companies, biotechnology firms, academic institutions, hospitals, diagnostic companies, and industrial biotechnology users.
From a commercial perspective, the proteomics industry demonstrates strong platform-based characteristics. High-end mass spectrometers and multiplex protein analysis systems typically adopt a business model combining instrument sales with recurring consumable revenues and maintenance services. Reagents and consumables generate higher recurring margins due to continuous demand and technological specialization. Software and bioinformatics platforms create additional value through algorithms, databases, and data interpretation capabilities, while CRO services improve efficiency through large-scale sample processing.
Overall, proteomics businesses generally achieve attractive gross margins. High-end analytical instruments and innovative protein analysis platforms typically generate gross margins of approximately 50%-70% due to significant technological barriers and customer qualification requirements. Specialized reagents, antibodies, and protein assay consumables may achieve gross margins of around 60%-80% because of recurring purchasing patterns and intellectual property advantages. Standardized testing services face stronger competition and generally maintain margins of approximately 30%-50%. Leading companies improve profitability through integrated ecosystems combining instruments, consumables, software, and services.
The proteomics market is entering a new stage of accelerated transition from academic research applications toward clinical translation and industrial commercialization. Growing demand for precision medicine, increasing investment in biopharmaceutical innovation, and deeper investigation of complex diseases are positioning proteomics as a critical technology platform in life sciences. Rising research activities in oncology, immunology, and neurodegenerative diseases continue to stimulate demand for highly sensitive, high-throughput, and multidimensional protein analysis technologies. Pharmaceutical companies are increasingly adopting proteomics for target discovery, mechanism-of-action studies, and companion diagnostics development to improve R&D efficiency and reduce development risks.
Despite strong growth prospects, the proteomics industry faces challenges including high technological complexity, expensive analytical platforms, sophisticated data interpretation requirements, and limited standardization across different workflows. Advanced mass spectrometry systems and next-generation protein analysis platforms require continuous investment in research and development. Furthermore, clinical validation, regulatory approval processes, and dependence on research funding cycles may create market uncertainties. Companies need to continuously strengthen technological innovation, automation capabilities, and bioinformatics expertise to maintain sustainable competitiveness.
Future demand for proteomics technologies will increasingly shift toward high-throughput analysis, clinical applications, and AI-driven biological interpretation. Pharmaceutical and biotechnology companies are expected to remain major growth engines by utilizing proteomics for innovative drug discovery and precision therapeutic development. Hospitals and diagnostic organizations are gradually exploring proteomics-based solutions for early disease detection, risk prediction, and companion diagnostics. Meanwhile, academic research will continue advancing single-cell proteomics, spatial proteomics, and multi-omics integration. With deeper integration of artificial intelligence, big data analytics, and automated laboratory platforms, proteomics is expected to become a fundamental infrastructure supporting future biomedical innovation and healthcare transformation.
LPI (LP Information)' newest research report, the “Proteomics Industry Forecast” looks at past sales and reviews total world Proteomics sales in 2025, providing a comprehensive analysis by region and market sector of projected Proteomics sales for 2026 through 2032. With Proteomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Proteomics industry.
This Insight Report provides a comprehensive analysis of the global Proteomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Proteomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Proteomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Proteomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Proteomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Proteomics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Proteomics Instruments
Proteomics Reagents
Proteomics Services
Proteomics Software
Segmentation by Proteomics Type:
Bulk Proteomics
Targeted/Affinity Preteomics
Spatial Proteomics
Single-Molecule Proteomics
Others
Segmentation by End User:
Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others
Segmentation by Application:
Clinical Diagnostics
Drug Discovery
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent Technologies
Merck KGaA
Danaher
Waters
Bio-Rad Laboratories
Bruker
Roche
PerkinElmer
Promega
Shimazdu
Talus Bio
G-Biosciences
Biodesix
Applied Biomics
Arbor Vita
Biosero
Illumina
Bio-Techne (Merck KGaA)
Qiagen
Sartorius
Charles River Laboratories
CellCarta
PTM BIO
Standard Biotools
Labcorp
BostonGene
APTBIO
Cell Signaling Technology (CST)
Inotiv
Bruker Spatial Biology
BGI Genomics
Biognosys
Crown Bioscience
Eurofins Scientific
Charles River Laboratories
Discovery Life Sciences
Shanghai OE Biotech
Biodesix
Novogene
OmicScouts (Momentum Biotechnologies)
Lc-Bio Technologies
Creative Proteomics
Metware Biotechnology
GENEWIZ (Azenta Life Sciences)
CDI Labs
Evotec
MS Bioworks
Shanghai Bioprofile
MtoZ-Biolabs

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Proteomics Market Size (2021-2032)
2.1.2 Proteomics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Proteomics by Country/Region (2021, 2025 & 2032)
2.2 Proteomics Segment by Type
2.2.1 Proteomics Instruments
2.2.2 Proteomics Reagents
2.2.3 Proteomics Services
2.2.4 Proteomics Software
2.2.5 Proteomics Market Size by Type
2.2.5.1 Proteomics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Proteomics Market Size Market Share by Type (2021-2026)
2.3 Proteomics Segment by Proteomics Type
2.3.1 Bulk Proteomics
2.3.2 Targeted/Affinity Preteomics
2.3.3 Spatial Proteomics
2.3.4 Single-Molecule Proteomics
2.3.5 Others
2.3.6 Proteomics Market Size by Proteomics Type
2.3.6.1 Proteomics Market Size CAGR by Proteomics Type (2021 VS 2025 VS 2032)
2.3.6.2 Global Proteomics Market Size Market Share by Proteomics Type (2021-2026)
2.4 Proteomics Segment by End User
2.4.1 Universities and Research Institutes
2.4.2 Hospitals
2.4.3 Pharmaceutical Companies
2.4.4 Others
2.4.5 Proteomics Market Size by End User
2.4.5.1 Proteomics Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.4.5.2 Global Proteomics Market Size Market Share by End User (2021-2026)
2.5 Proteomics Segment by Application
2.5.1 Clinical Diagnostics
2.5.2 Drug Discovery
2.5.3 Others
2.5.4 Proteomics Market Size by Application
2.5.4.1 Proteomics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Proteomics Market Size Market Share by Application (2021-2026)

3 Proteomics Market Size by Player
3.1 Proteomics Market Size Market Share by Player
3.1.1 Global Proteomics Revenue by Player (2021-2026)
3.1.2 Global Proteomics Revenue Market Share by Player (2021-2026)
3.2 Global Proteomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Proteomics by Region
4.1 Proteomics Market Size by Region (2021-2026)
4.2 Global Proteomics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Proteomics Market Size Growth (2021-2026)
4.4 APAC Proteomics Market Size Growth (2021-2026)
4.5 Europe Proteomics Market Size Growth (2021-2026)
4.6 Middle East & Africa Proteomics Market Size Growth (2021-2026)

5 Americas
5.1 Americas Proteomics Market Size by Country (2021-2026)
5.2 Americas Proteomics Market Size by Type (2021-2026)
5.3 Americas Proteomics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Proteomics Market Size by Region (2021-2026)
6.2 APAC Proteomics Market Size by Type (2021-2026)
6.3 APAC Proteomics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Proteomics Market Size by Country (2021-2026)
7.2 Europe Proteomics Market Size by Type (2021-2026)
7.3 Europe Proteomics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Proteomics by Region (2021-2026)
8.2 Middle East & Africa Proteomics Market Size by Type (2021-2026)
8.3 Middle East & Africa Proteomics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Proteomics Market Forecast
10.1 Global Proteomics Forecast by Region (2027-2032)
10.1.1 Global Proteomics Forecast by Region (2027-2032)
10.1.2 Americas Proteomics Forecast
10.1.3 APAC Proteomics Forecast
10.1.4 Europe Proteomics Forecast
10.1.5 Middle East & Africa Proteomics Forecast
10.2 Americas Proteomics Forecast by Country (2027-2032)
10.2.1 United States Market Proteomics Forecast
10.2.2 Canada Market Proteomics Forecast
10.2.3 Mexico Market Proteomics Forecast
10.2.4 Brazil Market Proteomics Forecast
10.3 APAC Proteomics Forecast by Region (2027-2032)
10.3.1 China Proteomics Market Forecast
10.3.2 Japan Market Proteomics Forecast
10.3.3 Korea Market Proteomics Forecast
10.3.4 Southeast Asia Market Proteomics Forecast
10.3.5 India Market Proteomics Forecast
10.3.6 Australia Market Proteomics Forecast
10.4 Europe Proteomics Forecast by Country (2027-2032)
10.4.1 Germany Market Proteomics Forecast
10.4.2 France Market Proteomics Forecast
10.4.3 UK Market Proteomics Forecast
10.4.4 Italy Market Proteomics Forecast
10.4.5 Russia Market Proteomics Forecast
10.5 Middle East & Africa Proteomics Forecast by Region (2027-2032)
10.5.1 Egypt Market Proteomics Forecast
10.5.2 South Africa Market Proteomics Forecast
10.5.3 Israel Market Proteomics Forecast
10.5.4 Turkey Market Proteomics Forecast
10.6 Global Proteomics Forecast by Type (2027-2032)
10.7 Global Proteomics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Proteomics Forecast

11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Proteomics Product Offered
11.1.3 Thermo Fisher Scientific Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies Proteomics Product Offered
11.2.3 Agilent Technologies Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Proteomics Product Offered
11.3.3 Merck KGaA Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Danaher
11.4.1 Danaher Company Information
11.4.2 Danaher Proteomics Product Offered
11.4.3 Danaher Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Danaher Main Business Overview
11.4.5 Danaher Latest Developments
11.5 Waters
11.5.1 Waters Company Information
11.5.2 Waters Proteomics Product Offered
11.5.3 Waters Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Waters Main Business Overview
11.5.5 Waters Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Proteomics Product Offered
11.6.3 Bio-Rad Laboratories Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
11.7 Bruker
11.7.1 Bruker Company Information
11.7.2 Bruker Proteomics Product Offered
11.7.3 Bruker Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Bruker Main Business Overview
11.7.5 Bruker Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Proteomics Product Offered
11.8.3 Roche Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 PerkinElmer
11.9.1 PerkinElmer Company Information
11.9.2 PerkinElmer Proteomics Product Offered
11.9.3 PerkinElmer Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 PerkinElmer Main Business Overview
11.9.5 PerkinElmer Latest Developments
11.10 Promega
11.10.1 Promega Company Information
11.10.2 Promega Proteomics Product Offered
11.10.3 Promega Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Promega Main Business Overview
11.10.5 Promega Latest Developments
11.11 Shimazdu
11.11.1 Shimazdu Company Information
11.11.2 Shimazdu Proteomics Product Offered
11.11.3 Shimazdu Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shimazdu Main Business Overview
11.11.5 Shimazdu Latest Developments
11.12 Talus Bio
11.12.1 Talus Bio Company Information
11.12.2 Talus Bio Proteomics Product Offered
11.12.3 Talus Bio Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Talus Bio Main Business Overview
11.12.5 Talus Bio Latest Developments
11.13 G-Biosciences
11.13.1 G-Biosciences Company Information
11.13.2 G-Biosciences Proteomics Product Offered
11.13.3 G-Biosciences Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 G-Biosciences Main Business Overview
11.13.5 G-Biosciences Latest Developments
11.14 Biodesix
11.14.1 Biodesix Company Information
11.14.2 Biodesix Proteomics Product Offered
11.14.3 Biodesix Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Biodesix Main Business Overview
11.14.5 Biodesix Latest Developments
11.15 Applied Biomics
11.15.1 Applied Biomics Company Information
11.15.2 Applied Biomics Proteomics Product Offered
11.15.3 Applied Biomics Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Applied Biomics Main Business Overview
11.15.5 Applied Biomics Latest Developments
11.16 Arbor Vita
11.16.1 Arbor Vita Company Information
11.16.2 Arbor Vita Proteomics Product Offered
11.16.3 Arbor Vita Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Arbor Vita Main Business Overview
11.16.5 Arbor Vita Latest Developments
11.17 Biosero
11.17.1 Biosero Company Information
11.17.2 Biosero Proteomics Product Offered
11.17.3 Biosero Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Biosero Main Business Overview
11.17.5 Biosero Latest Developments
11.18 Illumina
11.18.1 Illumina Company Information
11.18.2 Illumina Proteomics Product Offered
11.18.3 Illumina Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Illumina Main Business Overview
11.18.5 Illumina Latest Developments
11.19 Bio-Techne (Merck KGaA)
11.19.1 Bio-Techne (Merck KGaA) Company Information
11.19.2 Bio-Techne (Merck KGaA) Proteomics Product Offered
11.19.3 Bio-Techne (Merck KGaA) Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Bio-Techne (Merck KGaA) Main Business Overview
11.19.5 Bio-Techne (Merck KGaA) Latest Developments
11.20 Qiagen
11.20.1 Qiagen Company Information
11.20.2 Qiagen Proteomics Product Offered
11.20.3 Qiagen Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Qiagen Main Business Overview
11.20.5 Qiagen Latest Developments
11.21 Sartorius
11.21.1 Sartorius Company Information
11.21.2 Sartorius Proteomics Product Offered
11.21.3 Sartorius Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Sartorius Main Business Overview
11.21.5 Sartorius Latest Developments
11.22 Charles River Laboratories
11.22.1 Charles River Laboratories Company Information
11.22.2 Charles River Laboratories Proteomics Product Offered
11.22.3 Charles River Laboratories Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Charles River Laboratories Main Business Overview
11.22.5 Charles River Laboratories Latest Developments
11.23 CellCarta
11.23.1 CellCarta Company Information
11.23.2 CellCarta Proteomics Product Offered
11.23.3 CellCarta Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 CellCarta Main Business Overview
11.23.5 CellCarta Latest Developments
11.24 PTM BIO
11.24.1 PTM BIO Company Information
11.24.2 PTM BIO Proteomics Product Offered
11.24.3 PTM BIO Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 PTM BIO Main Business Overview
11.24.5 PTM BIO Latest Developments
11.25 Standard Biotools
11.25.1 Standard Biotools Company Information
11.25.2 Standard Biotools Proteomics Product Offered
11.25.3 Standard Biotools Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Standard Biotools Main Business Overview
11.25.5 Standard Biotools Latest Developments
11.26 Labcorp
11.26.1 Labcorp Company Information
11.26.2 Labcorp Proteomics Product Offered
11.26.3 Labcorp Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Labcorp Main Business Overview
11.26.5 Labcorp Latest Developments
11.27 BostonGene
11.27.1 BostonGene Company Information
11.27.2 BostonGene Proteomics Product Offered
11.27.3 BostonGene Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 BostonGene Main Business Overview
11.27.5 BostonGene Latest Developments
11.28 APTBIO
11.28.1 APTBIO Company Information
11.28.2 APTBIO Proteomics Product Offered
11.28.3 APTBIO Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 APTBIO Main Business Overview
11.28.5 APTBIO Latest Developments
11.29 Cell Signaling Technology (CST)
11.29.1 Cell Signaling Technology (CST) Company Information
11.29.2 Cell Signaling Technology (CST) Proteomics Product Offered
11.29.3 Cell Signaling Technology (CST) Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 Cell Signaling Technology (CST) Main Business Overview
11.29.5 Cell Signaling Technology (CST) Latest Developments
11.30 Inotiv
11.30.1 Inotiv Company Information
11.30.2 Inotiv Proteomics Product Offered
11.30.3 Inotiv Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Inotiv Main Business Overview
11.30.5 Inotiv Latest Developments
11.31 Bruker Spatial Biology
11.31.1 Bruker Spatial Biology Company Information
11.31.2 Bruker Spatial Biology Proteomics Product Offered
11.31.3 Bruker Spatial Biology Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Bruker Spatial Biology Main Business Overview
11.31.5 Bruker Spatial Biology Latest Developments
11.32 BGI Genomics
11.32.1 BGI Genomics Company Information
11.32.2 BGI Genomics Proteomics Product Offered
11.32.3 BGI Genomics Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 BGI Genomics Main Business Overview
11.32.5 BGI Genomics Latest Developments
11.33 Biognosys
11.33.1 Biognosys Company Information
11.33.2 Biognosys Proteomics Product Offered
11.33.3 Biognosys Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Biognosys Main Business Overview
11.33.5 Biognosys Latest Developments
11.34 Crown Bioscience
11.34.1 Crown Bioscience Company Information
11.34.2 Crown Bioscience Proteomics Product Offered
11.34.3 Crown Bioscience Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 Crown Bioscience Main Business Overview
11.34.5 Crown Bioscience Latest Developments
11.35 Eurofins Scientific
11.35.1 Eurofins Scientific Company Information
11.35.2 Eurofins Scientific Proteomics Product Offered
11.35.3 Eurofins Scientific Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Eurofins Scientific Main Business Overview
11.35.5 Eurofins Scientific Latest Developments
11.36 Charles River Laboratories
11.36.1 Charles River Laboratories Company Information
11.36.2 Charles River Laboratories Proteomics Product Offered
11.36.3 Charles River Laboratories Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 Charles River Laboratories Main Business Overview
11.36.5 Charles River Laboratories Latest Developments
11.37 Discovery Life Sciences
11.37.1 Discovery Life Sciences Company Information
11.37.2 Discovery Life Sciences Proteomics Product Offered
11.37.3 Discovery Life Sciences Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 Discovery Life Sciences Main Business Overview
11.37.5 Discovery Life Sciences Latest Developments
11.38 Shanghai OE Biotech
11.38.1 Shanghai OE Biotech Company Information
11.38.2 Shanghai OE Biotech Proteomics Product Offered
11.38.3 Shanghai OE Biotech Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Shanghai OE Biotech Main Business Overview
11.38.5 Shanghai OE Biotech Latest Developments
11.39 Biodesix
11.39.1 Biodesix Company Information
11.39.2 Biodesix Proteomics Product Offered
11.39.3 Biodesix Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Biodesix Main Business Overview
11.39.5 Biodesix Latest Developments
11.40 Novogene
11.40.1 Novogene Company Information
11.40.2 Novogene Proteomics Product Offered
11.40.3 Novogene Proteomics Revenue, Gross Margin and Market Share (2021-2026)
11.40.4 Novogene Main Business Overview
11.40.5 Novogene Latest Developments

12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Proteomics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Proteomics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Proteomics Instruments
Table 4. Major Players of Proteomics Reagents
Table 5. Major Players of Proteomics Services
Table 6. Major Players of Proteomics Software
Table 7. Proteomics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Proteomics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Proteomics Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Bulk Proteomics
Table 11. Major Players of Targeted/Affinity Preteomics
Table 12. Major Players of Spatial Proteomics
Table 13. Major Players of Single-Molecule Proteomics
Table 14. Major Players of Others
Table 15. Proteomics Market Size CAGR by Proteomics Type (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Proteomics Market Size by Proteomics Type (2021-2026) & ($ millions)
Table 17. Global Proteomics Market Size Market Share by Proteomics Type (2021-2026)
Table 18. Major Players of Universities and Research Institutes
Table 19. Major Players of Hospitals
Table 20. Major Players of Pharmaceutical Companies
Table 21. Major Players of Others
Table 22. Proteomics Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Proteomics Market Size by End User (2021-2026) & ($ millions)
Table 24. Global Proteomics Market Size Market Share by End User (2021-2026)
Table 25. Proteomics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Proteomics Market Size by Application (2021-2026) & ($ millions)
Table 27. Global Proteomics Market Size Market Share by Application (2021-2026)
Table 28. Global Proteomics Revenue by Player (2021-2026) & ($ millions)
Table 29. Global Proteomics Revenue Market Share by Player (2021-2026)
Table 30. Proteomics Key Players Head office and Products Offered
Table 31. Proteomics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Mergers & Acquisitions, Expansion
Table 34. Global Proteomics Market Size by Region (2021-2026) & ($ millions)
Table 35. Global Proteomics Market Size Market Share by Region (2021-2026)
Table 36. Global Proteomics Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Proteomics Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Proteomics Market Size by Country (2021-2026) & ($ millions)
Table 39. Americas Proteomics Market Size Market Share by Country (2021-2026)
Table 40. Americas Proteomics Market Size by Type (2021-2026) & ($ millions)
Table 41. Americas Proteomics Market Size Market Share by Type (2021-2026)
Table 42. Americas Proteomics Market Size by Application (2021-2026) & ($ millions)
Table 43. Americas Proteomics Market Size Market Share by Application (2021-2026)
Table 44. APAC Proteomics Market Size by Region (2021-2026) & ($ millions)
Table 45. APAC Proteomics Market Size Market Share by Region (2021-2026)
Table 46. APAC Proteomics Market Size by Type (2021-2026) & ($ millions)
Table 47. APAC Proteomics Market Size by Application (2021-2026) & ($ millions)
Table 48. Europe Proteomics Market Size by Country (2021-2026) & ($ millions)
Table 49. Europe Proteomics Market Size Market Share by Country (2021-2026)
Table 50. Europe Proteomics Market Size by Type (2021-2026) & ($ millions)
Table 51. Europe Proteomics Market Size by Application (2021-2026) & ($ millions)
Table 52. Middle East & Africa Proteomics Market Size by Region (2021-2026) & ($ millions)
Table 53. Middle East & Africa Proteomics Market Size by Type (2021-2026) & ($ millions)
Table 54. Middle East & Africa Proteomics Market Size by Application (2021-2026) & ($ millions)
Table 55. Key Market Drivers & Growth Opportunities of Proteomics
Table 56. Key Market Challenges & Risks of Proteomics
Table 57. Key Industry Trends of Proteomics
Table 58. Global Proteomics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 59. Global Proteomics Market Size Market Share Forecast by Region (2027-2032)
Table 60. Global Proteomics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 61. Global Proteomics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 62. Thermo Fisher Scientific Details, Company Type, Proteomics Area Served and Its Competitors
Table 63. Thermo Fisher Scientific Proteomics Product Offered
Table 64. Thermo Fisher Scientific Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Latest Developments
Table 67. Agilent Technologies Details, Company Type, Proteomics Area Served and Its Competitors
Table 68. Agilent Technologies Proteomics Product Offered
Table 69. Agilent Technologies Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Agilent Technologies Main Business
Table 71. Agilent Technologies Latest Developments
Table 72. Merck KGaA Details, Company Type, Proteomics Area Served and Its Competitors
Table 73. Merck KGaA Proteomics Product Offered
Table 74. Merck KGaA Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Merck KGaA Main Business
Table 76. Merck KGaA Latest Developments
Table 77. Danaher Details, Company Type, Proteomics Area Served and Its Competitors
Table 78. Danaher Proteomics Product Offered
Table 79. Danaher Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Danaher Main Business
Table 81. Danaher Latest Developments
Table 82. Waters Details, Company Type, Proteomics Area Served and Its Competitors
Table 83. Waters Proteomics Product Offered
Table 84. Waters Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Waters Main Business
Table 86. Waters Latest Developments
Table 87. Bio-Rad Laboratories Details, Company Type, Proteomics Area Served and Its Competitors
Table 88. Bio-Rad Laboratories Proteomics Product Offered
Table 89. Bio-Rad Laboratories Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Bio-Rad Laboratories Main Business
Table 91. Bio-Rad Laboratories Latest Developments
Table 92. Bruker Details, Company Type, Proteomics Area Served and Its Competitors
Table 93. Bruker Proteomics Product Offered
Table 94. Bruker Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Bruker Main Business
Table 96. Bruker Latest Developments
Table 97. Roche Details, Company Type, Proteomics Area Served and Its Competitors
Table 98. Roche Proteomics Product Offered
Table 99. Roche Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Roche Main Business
Table 101. Roche Latest Developments
Table 102. PerkinElmer Details, Company Type, Proteomics Area Served and Its Competitors
Table 103. PerkinElmer Proteomics Product Offered
Table 104. PerkinElmer Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. PerkinElmer Main Business
Table 106. PerkinElmer Latest Developments
Table 107. Promega Details, Company Type, Proteomics Area Served and Its Competitors
Table 108. Promega Proteomics Product Offered
Table 109. Promega Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Promega Main Business
Table 111. Promega Latest Developments
Table 112. Shimazdu Details, Company Type, Proteomics Area Served and Its Competitors
Table 113. Shimazdu Proteomics Product Offered
Table 114. Shimazdu Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Shimazdu Main Business
Table 116. Shimazdu Latest Developments
Table 117. Talus Bio Details, Company Type, Proteomics Area Served and Its Competitors
Table 118. Talus Bio Proteomics Product Offered
Table 119. Talus Bio Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Talus Bio Main Business
Table 121. Talus Bio Latest Developments
Table 122. G-Biosciences Details, Company Type, Proteomics Area Served and Its Competitors
Table 123. G-Biosciences Proteomics Product Offered
Table 124. G-Biosciences Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. G-Biosciences Main Business
Table 126. G-Biosciences Latest Developments
Table 127. Biodesix Details, Company Type, Proteomics Area Served and Its Competitors
Table 128. Biodesix Proteomics Product Offered
Table 129. Biodesix Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Biodesix Main Business
Table 131. Biodesix Latest Developments
Table 132. Applied Biomics Details, Company Type, Proteomics Area Served and Its Competitors
Table 133. Applied Biomics Proteomics Product Offered
Table 134. Applied Biomics Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Applied Biomics Main Business
Table 136. Applied Biomics Latest Developments
Table 137. Arbor Vita Details, Company Type, Proteomics Area Served and Its Competitors
Table 138. Arbor Vita Proteomics Product Offered
Table 139. Arbor Vita Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Arbor Vita Main Business
Table 141. Arbor Vita Latest Developments
Table 142. Biosero Details, Company Type, Proteomics Area Served and Its Competitors
Table 143. Biosero Proteomics Product Offered
Table 144. Biosero Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Biosero Main Business
Table 146. Biosero Latest Developments
Table 147. Illumina Details, Company Type, Proteomics Area Served and Its Competitors
Table 148. Illumina Proteomics Product Offered
Table 149. Illumina Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Illumina Main Business
Table 151. Illumina Latest Developments
Table 152. Bio-Techne (Merck KGaA) Details, Company Type, Proteomics Area Served and Its Competitors
Table 153. Bio-Techne (Merck KGaA) Proteomics Product Offered
Table 154. Bio-Techne (Merck KGaA) Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. Bio-Techne (Merck KGaA) Main Business
Table 156. Bio-Techne (Merck KGaA) Latest Developments
Table 157. Qiagen Details, Company Type, Proteomics Area Served and Its Competitors
Table 158. Qiagen Proteomics Product Offered
Table 159. Qiagen Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Qiagen Main Business
Table 161. Qiagen Latest Developments
Table 162. Sartorius Details, Company Type, Proteomics Area Served and Its Competitors
Table 163. Sartorius Proteomics Product Offered
Table 164. Sartorius Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. Sartorius Main Business
Table 166. Sartorius Latest Developments
Table 167. Charles River Laboratories Details, Company Type, Proteomics Area Served and Its Competitors
Table 168. Charles River Laboratories Proteomics Product Offered
Table 169. Charles River Laboratories Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Charles River Laboratories Main Business
Table 171. Charles River Laboratories Latest Developments
Table 172. CellCarta Details, Company Type, Proteomics Area Served and Its Competitors
Table 173. CellCarta Proteomics Product Offered
Table 174. CellCarta Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. CellCarta Main Business
Table 176. CellCarta Latest Developments
Table 177. PTM BIO Details, Company Type, Proteomics Area Served and Its Competitors
Table 178. PTM BIO Proteomics Product Offered
Table 179. PTM BIO Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. PTM BIO Main Business
Table 181. PTM BIO Latest Developments
Table 182. Standard Biotools Details, Company Type, Proteomics Area Served and Its Competitors
Table 183. Standard Biotools Proteomics Product Offered
Table 184. Standard Biotools Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. Standard Biotools Main Business
Table 186. Standard Biotools Latest Developments
Table 187. Labcorp Details, Company Type, Proteomics Area Served and Its Competitors
Table 188. Labcorp Proteomics Product Offered
Table 189. Labcorp Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 190. Labcorp Main Business
Table 191. Labcorp Latest Developments
Table 192. BostonGene Details, Company Type, Proteomics Area Served and Its Competitors
Table 193. BostonGene Proteomics Product Offered
Table 194. BostonGene Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 195. BostonGene Main Business
Table 196. BostonGene Latest Developments
Table 197. APTBIO Details, Company Type, Proteomics Area Served and Its Competitors
Table 198. APTBIO Proteomics Product Offered
Table 199. APTBIO Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 200. APTBIO Main Business
Table 201. APTBIO Latest Developments
Table 202. Cell Signaling Technology (CST) Details, Company Type, Proteomics Area Served and Its Competitors
Table 203. Cell Signaling Technology (CST) Proteomics Product Offered
Table 204. Cell Signaling Technology (CST) Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 205. Cell Signaling Technology (CST) Main Business
Table 206. Cell Signaling Technology (CST) Latest Developments
Table 207. Inotiv Details, Company Type, Proteomics Area Served and Its Competitors
Table 208. Inotiv Proteomics Product Offered
Table 209. Inotiv Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 210. Inotiv Main Business
Table 211. Inotiv Latest Developments
Table 212. Bruker Spatial Biology Details, Company Type, Proteomics Area Served and Its Competitors
Table 213. Bruker Spatial Biology Proteomics Product Offered
Table 214. Bruker Spatial Biology Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 215. Bruker Spatial Biology Main Business
Table 216. Bruker Spatial Biology Latest Developments
Table 217. BGI Genomics Details, Company Type, Proteomics Area Served and Its Competitors
Table 218. BGI Genomics Proteomics Product Offered
Table 219. BGI Genomics Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 220. BGI Genomics Main Business
Table 221. BGI Genomics Latest Developments
Table 222. Biognosys Details, Company Type, Proteomics Area Served and Its Competitors
Table 223. Biognosys Proteomics Product Offered
Table 224. Biognosys Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 225. Biognosys Main Business
Table 226. Biognosys Latest Developments
Table 227. Crown Bioscience Details, Company Type, Proteomics Area Served and Its Competitors
Table 228. Crown Bioscience Proteomics Product Offered
Table 229. Crown Bioscience Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 230. Crown Bioscience Main Business
Table 231. Crown Bioscience Latest Developments
Table 232. Eurofins Scientific Details, Company Type, Proteomics Area Served and Its Competitors
Table 233. Eurofins Scientific Proteomics Product Offered
Table 234. Eurofins Scientific Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 235. Eurofins Scientific Main Business
Table 236. Eurofins Scientific Latest Developments
Table 237. Charles River Laboratories Details, Company Type, Proteomics Area Served and Its Competitors
Table 238. Charles River Laboratories Proteomics Product Offered
Table 239. Charles River Laboratories Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 240. Charles River Laboratories Main Business
Table 241. Charles River Laboratories Latest Developments
Table 242. Discovery Life Sciences Details, Company Type, Proteomics Area Served and Its Competitors
Table 243. Discovery Life Sciences Proteomics Product Offered
Table 244. Discovery Life Sciences Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 245. Discovery Life Sciences Main Business
Table 246. Discovery Life Sciences Latest Developments
Table 247. Shanghai OE Biotech Details, Company Type, Proteomics Area Served and Its Competitors
Table 248. Shanghai OE Biotech Proteomics Product Offered
Table 249. Shanghai OE Biotech Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 250. Shanghai OE Biotech Main Business
Table 251. Shanghai OE Biotech Latest Developments
Table 252. Biodesix Details, Company Type, Proteomics Area Served and Its Competitors
Table 253. Biodesix Proteomics Product Offered
Table 254. Biodesix Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 255. Biodesix Main Business
Table 256. Biodesix Latest Developments
Table 257. Novogene Details, Company Type, Proteomics Area Served and Its Competitors
Table 258. Novogene Proteomics Product Offered
Table 259. Novogene Proteomics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 260. Novogene Main Business
Table 261. Novogene Latest Developments

List of Figures
Figure 1. Proteomics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Proteomics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Proteomics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Proteomics Sales Market Share by Country/Region (2025)
Figure 8. Proteomics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Proteomics Market Size Market Share by Type in 2025
Figure 10. Global Proteomics Market Size Market Share by Proteomics Type in 2025
Figure 11. Global Proteomics Market Size Market Share by End User in 2025
Figure 12. Proteomics in Clinical Diagnostics
Figure 13. Global Proteomics Market: Clinical Diagnostics (2021-2026) & ($ millions)
Figure 14. Proteomics in Drug Discovery
Figure 15. Global Proteomics Market: Drug Discovery (2021-2026) & ($ millions)
Figure 16. Proteomics in Others
Figure 17. Global Proteomics Market: Others (2021-2026) & ($ millions)
Figure 18. Global Proteomics Market Size Market Share by Application in 2025
Figure 19. Global Proteomics Revenue Market Share by Player in 2025
Figure 20. Global Proteomics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Proteomics Market Size 2021-2026 ($ millions)
Figure 22. APAC Proteomics Market Size 2021-2026 ($ millions)
Figure 23. Europe Proteomics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Proteomics Market Size 2021-2026 ($ millions)
Figure 25. Americas Proteomics Value Market Share by Country in 2025
Figure 26. United States Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Proteomics Market Size Market Share by Region in 2025
Figure 31. APAC Proteomics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Proteomics Market Size Market Share by Application (2021-2026)
Figure 33. China Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Proteomics Market Size Market Share by Country in 2025
Figure 40. Europe Proteomics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Proteomics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Proteomics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Proteomics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Proteomics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Proteomics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Proteomics Market Size 2027-2032 ($ millions)
Figure 56. APAC Proteomics Market Size 2027-2032 ($ millions)
Figure 57. Europe Proteomics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Proteomics Market Size 2027-2032 ($ millions)
Figure 59. United States Proteomics Market Size 2027-2032 ($ millions)
Figure 60. Canada Proteomics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Proteomics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Proteomics Market Size 2027-2032 ($ millions)
Figure 63. China Proteomics Market Size 2027-2032 ($ millions)
Figure 64. Japan Proteomics Market Size 2027-2032 ($ millions)
Figure 65. Korea Proteomics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Proteomics Market Size 2027-2032 ($ millions)
Figure 67. India Proteomics Market Size 2027-2032 ($ millions)
Figure 68. Australia Proteomics Market Size 2027-2032 ($ millions)
Figure 69. Germany Proteomics Market Size 2027-2032 ($ millions)
Figure 70. France Proteomics Market Size 2027-2032 ($ millions)
Figure 71. UK Proteomics Market Size 2027-2032 ($ millions)
Figure 72. Italy Proteomics Market Size 2027-2032 ($ millions)
Figure 73. Russia Proteomics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Proteomics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Proteomics Market Size 2027-2032 ($ millions)
Figure 76. Israel Proteomics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Proteomics Market Size 2027-2032 ($ millions)
Figure 78. Global Proteomics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Proteomics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Proteomics Market Size 2027-2032 ($ millions)